Kezar Life Sciences
37 hedge funds and large institutions have $194M invested in Kezar Life Sciences in 2018 Q3 according to their latest regulatory filings, with 20 funds opening new positions, 5 increasing their positions, 8 reducing their positions, and 9 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding in top 10
Funds holding in top 10: →
more capital invested
Capital invested by funds: $ → $
more funds holding
Funds holding: →
0.51% more ownership
Funds ownership: 4.23% → 4.74% (+0.51%)
38% less repeat investments, than reductions
Existing positions increased: 5 | Existing positions reduced: 8
Holders
37
Holding in Top 10
2
Calls
–
Puts
–
Top Buyers
| 1 | +$22M | |
| 2 | +$4.95M | |
| 3 | +$1.15M | |
| 4 |
Northern Trust
Chicago,
Illinois
|
+$1.12M |
| 5 |
State Street
Boston,
Massachusetts
|
+$849K |
Top Sellers
| 1 | -$1.73M | |
| 2 | -$1.73M | |
| 3 | -$1.33M | |
| 4 |
Alyeska Investment Group
Chicago,
Illinois
|
-$1.3M |
| 5 |
SM
Sabby Management
Miami Beach,
Florida
|
-$735K |